These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 14632536

  • 1. Mycophenolate pharmacokinetics in early period following lung or heart transplantation.
    Ensom MH, Partovi N, Decarie D, Ignaszewski AP, Fradet GJ, Levy RD.
    Ann Pharmacother; 2003 Dec; 37(12):1761-7. PubMed ID: 14632536
    [Abstract] [Full Text] [Related]

  • 2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 4. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
    [Abstract] [Full Text] [Related]

  • 6. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M, Shapiro RJ, Partovi N, Ting LS, Levine M, Ensom MH.
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [Abstract] [Full Text] [Related]

  • 7. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B, Chen B, Zhang W, Mao H, Shen C, Deng X, Zhan X, Chen H.
    Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
    [Abstract] [Full Text] [Related]

  • 8. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
    Jain AB, Hamad I, Zuckerman S, Zhang S, Warty VS, Fung JJ, Venkataramanan R.
    Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348
    [Abstract] [Full Text] [Related]

  • 9. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK, Park JM, Lake KD.
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [Abstract] [Full Text] [Related]

  • 10. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
    Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.
    Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W, Ficheux M, Debruyne D, Rognant N, Lobbedez T, Allard C, Coquerel A, Ryckelynck JP, Hurault de Ligny B.
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
    Nazemian F, Mohammadpur AH, Abtahi B, Naghibi M.
    Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
    [Abstract] [Full Text] [Related]

  • 13. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Ostrowska J, Gralak B, Majchrzak J.
    Transplant Proc; 2006 Dec; 38(1):86-9. PubMed ID: 16504671
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients.
    Ensom MH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD.
    Ther Drug Monit; 2002 Apr; 24(2):310-4. PubMed ID: 11897977
    [Abstract] [Full Text] [Related]

  • 15. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients.
    Johnson AG, Rigby RJ, Taylor PJ, Jones CE, Allen J, Franzen K, Falk MC, Nicol D.
    Clin Pharmacol Ther; 1999 Nov; 66(5):492-500. PubMed ID: 10579476
    [Abstract] [Full Text] [Related]

  • 16. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B, David-Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, Kuypers DR, Tsai E, Vinks AA, Weber LT, Zimmerhackl LB.
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic evaluation of mycophenolic acid profiles during the period immediately following an orthotopic liver transplant.
    Fatela-Cantillo D, Hinojosa-Pérez R, Peralvo-Rodríguez MI, Serrano-Díaz Canedo J, Gómez-Bravo MA.
    Transplant Proc; 2006 Oct; 38(8):2482-5. PubMed ID: 17097975
    [Abstract] [Full Text] [Related]

  • 18. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M.
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.
    Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.